GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $739,000 | -44.8% | 20,700 | -42.5% | 0.16% | -48.9% |
| Q4 2020 | $1,339,000 | -0.6% | 36,000 | 0.0% | 0.30% | -16.7% |
| Q3 2020 | $1,347,000 | +65.1% | 36,000 | +80.0% | 0.37% | -7.8% |
| Q2 2020 | $816,000 | +247.2% | 20,000 | +300.0% | 0.40% | +649.1% |
| Q4 2019 | $235,000 | +15.2% | 5,000 | 0.0% | 0.05% | +8.2% |
| Q3 2019 | $204,000 | +1.5% | 5,000 | 0.0% | 0.05% | -5.8% |
| Q2 2019 | $201,000 | -81.7% | 5,000 | -81.5% | 0.05% | -72.5% |
| Q1 2016 | $1,097,000 | – | 27,056 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |